| 
			
			 The move comes as health and law enforcement officials try to curb a 
			rising tide of prescription drug abuse. Nearly three out of four 
			prescription drug overdoses are caused by opioid painkillers, 
			according to federal data. 
 "Almost seven million Americans abuse controlled-substance 
			prescription medications, including opioid painkillers, resulting in 
			more deaths from prescription drug overdoses than auto accidents," 
			DEA Administrator Michele Leonhart said in a statement announcing 
			the move on Thursday.
 
 In the future, products such as Vicodin that combine hydrocodone 
			with another substance such as acetaminophen or aspirin, will be 
			classed as Schedule II products, in line with the opioids oxycodone 
			and morphine.
 
			
			 
			Reclassifying the products will make them harder to obtain, both by 
			addicts and legitimate pain patients. Physicians will not be allowed 
			to call in a prescription to a pharmacy. Patients will have to 
			present a written prescription.
 Also, fewer refills will be allowed before patients must return to 
			see their doctor. Opponents of the reclassification, which has been 
			in the works for several years, argue that restricting pain products 
			could cause hardship to patients with chronic illnesses, especially 
			the elderly.
 
 Hydrocodone itself has been a Schedule II drug for decades, but 
			combination products have had a less restrictive Schedule III 
			designation. The DEA said that products that combine hydrocodone 
			with another drug - acetaminophen in the case of Vicodin - are still 
			highly addictive.
 
 [to top of second column]
 | 
 
			"Today's action recognizes that these products are some of the most 
			addictive and potentially dangerous prescription medications 
			available," Leonhart said.
 Vicodin is made by AbbVie. Other brand names containing hydrocodone 
			in combination with another drug include Lortab, made by UCB.
 
 (Reporting by Toni Clarke in Washington; editing by Gunna Dickson 
			and Frances Kerry)
 
 
			[© 2014 Thomson Reuters. All rights 
				reserved.] Copyright 2014 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed. 
			
			 |